Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Diagnosis of multiple sclerosis - the 2010 revision of the McDonald criteria.]
Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research.
Lymphomatoid papulosis type D in a fingolimod-treated multiple sclerosis patient.
Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis.
The cost burden of multiple sclerosis in the United States: a systematic review of the literature.
Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects with Multiple Sclerosis
Amiloride Clinical Trial In Optic Neuritis (ACTION)
The little compound that could: how phenytoin changed drug discovery and development.
Unusual case of gastroparesis leading to severe gastromegaly with demyelinating disease as a rare cause.
Eicosapentaenoic acid (EPA) induces peroxisome proliferator-activated receptors and ameliorates experimental autoimmune encephalomyelitis.
Effects of natalizumab treatment on the CSF proteome of multiple sclerosis patients.
Managing fatigue in patients with multiple sclerosis.
The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia.
Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes.
Normal outcome of pregnancy with ongoing treatment with natalizumab.
Phase IV Study Reports Multiple Sclerosis Success with Teriflunomide
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis.
Treatment of walking impairment in multiple sclerosis with dalfampridine.
The Submaximal Clinical Exercise Tolerance Test (SXTT) to Establish Safe Exercise Prescription Parameters for Patients with Chronic Disease and Disability.
The AusD Study: A Population-based Study of the Determinants of Serum 25-Hydroxyvitamin D Concentration Across a Broad Latitude Range.
The influence of ethnicity on the characteristics of multiple sclerosis: A local population study between Persians and Arabs.
UVB light attenuates the systemic immune response in CNS autoimmunity.
The investigation of acute optic neuritis: a review and proposed protocol.
Possible pathogenic engagement of soluble Semaphorin 4D produced by γδT cells in medication-related osteonecrosis of the jaw (MRONJ).
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1-images in multiple sclerosis.
Pages
« first
‹ previous
…
145
146
147
148
149
150
151
152
153
…
next ›
last »